LIPOSORBER® Provides Hope When Drug Therapy Fails™

LIPOSORBER is an extracorporeal therapy that enables patients to attain the recommended therapeutic targets when diet and maximum drug therapies have failed or are not tolerated. LIPOSORBER is shown to acutely reduce harmful cholesterol agents: Low-Density Lipoprotein Cholesterol (LDL-C), Lipoprotein(a) [Lp(a)].1

Mary N. – Familial Hypercholesterolemia (FH) Patient Story

Cardiovascular Disease

Treatment with LIPOSORBER can help Familial Hypercholesterolemia (FH) patients reduce coronary events
by 72%.2*

Kidney Disease

Treatment with LIPOSORBER has enabled nearly 50% of steroid-resistant primary FSGS patients to attain complete or partial remission.3**

Locate a Treatment Center Near You

LIPOSORBER® has more than 50 treatment locations throughout the country.

Are you a candidate for LIPOSORBER® Therapy?

LIPOSORBER is an FDA approved device that removes low-density lipoprotein cholesterol (LDL-C) and Lipoprotein(a) [Lp(a)] from the blood. Approximately 600,000 treatments have been performed worldwide on over 6,000 patients. Could LIPOSORBER be a treatment option for you? Click below to find out.